Product Profiles

Article

A round-up of the latest ophthalmic products

Cefuroxime preparation for intracameral use

The powder solution for injection is administered with 5 mL of sterile sodium chloride 0.9%, meaning dilution and preparation mistakes can easily be avoided. APROKAM is available in single doses or in boxes of ten vials and each vial is labelled to ensure traceability of the product within each patient's file.

For further details please visit http://www.laboratoires-thea.com/

Pan retinal laser lens

The lens features a flanged contact element for greater stability, as well as providing distortion-free vision. With a double aspheric glass design, the lens reportedly provides the highest resolution imaging across the whole viewing field.

Manipulation of the lens is simplified due to the lens' reduced size. This gives the lens superior viewing power and better image quality. Available with 50x magnification and 2.0x laser magnification, the H-R Wide Field is ideal for wide field diagnosis and pan retinal photocoagulation laser treatment.

For further details please visit http://www.volk.com/

Silicone oil tamponades

The silicone oil can be used to fill the eye after retinal surgery. This provides good stabilization of the retina. When the oil has been removed after the retina has been reattached, the gas is reabsorbed into the eye and no additional surgery is required.

The ready-to-use gas syringes eradicate the need for large gas containers, meaning only the gas-air mixture has to be adjusted. Each gas is colour-coded for ease of use and access. The gas can even be used in low-light conditions due to the good contrast and bright colours.

Please visit http://www.alamedics.de/ for more information

Posterior segment instruments

The instruments are now available in 20, 23 and 25 gauge ranges. New additions to the Uno Colorline range include one-use vitrectomy scissors for precise and hygienic cuts and a trocar chandelier set for high illumination.

Also included in the set are a variety of vitrectomy forceps, a trocar system and a one-use laser probe for a number of laser consoles.

Geuder also offers instruments that can be used in conjunction with the Uno Colorline range. This includes the Shark retaining ring, the Triangle sclera depressor and the Horse Shoe instrument.

For more information please visit http://www.geuder.de/

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.